For Diana Perez, a medical resident at the Family Health Center of Harlem, the handwritten thank-you note she received from a patient is all the evidence she needs that she has chosen the right training path.
ADC manufacturing will likely stay with established CDMOs due to high barrier to market entry
Antibody-drug conjugate (ADCs) manufacturing is likely to remain among CDMOs already making them due to demanding market entry requirements, executives in the ADC space said.